Immix Biopharma Stock Price History
IMMX Stock | USD 1.68 0.14 7.69% |
If you're considering investing in Immix Stock, it is important to understand the factors that can impact its price. As of today, the current price of Immix Biopharma stands at 1.68, as last reported on the 22nd of November, with the highest price reaching 1.89 and the lowest price hitting 1.65 during the day. Immix Biopharma holds Efficiency (Sharpe) Ratio of -0.0445, which attests that the entity had a -0.0445% return per unit of risk over the last 3 months. Immix Biopharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immix Biopharma's Standard Deviation of 5.47, risk adjusted performance of (0.04), and Market Risk Adjusted Performance of (0.25) to validate the risk estimate we provide.
Stock Based Compensation is likely to rise to about 2.7 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 8.6 M in 2024. . At this time, Immix Biopharma's Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 7.68 in 2024, whereas Price To Sales Ratio is likely to drop (0.32) in 2024. Immix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Immix |
Sharpe Ratio = -0.0445
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | IMMX |
Estimated Market Risk
5.54 actual daily | 49 51% of assets are more volatile |
Expected Return
-0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Immix Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immix Biopharma by adding Immix Biopharma to a well-diversified portfolio.
Price Book 2.6331 | Book Value 0.823 | Enterprise Value 27.6 M | Enterprise Value Ebitda (0.37) | Shares Float 14.5 M |
Immix Biopharma Stock Price History Chart
There are several ways to analyze Immix Stock price data. The simplest method is using a basic Immix candlestick price chart, which shows Immix Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | August 30, 2024 | 2.14 |
Lowest Price | October 3, 2024 | 1.34 |
Immix Biopharma November 22, 2024 Stock Price Synopsis
Various analyses of Immix Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Immix Stock. It can be used to describe the percentage change in the price of Immix Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Immix Stock.Immix Biopharma Price Rate Of Daily Change | 0.92 | |
Immix Biopharma Price Daily Balance Of Power | (0.58) | |
Immix Biopharma Price Action Indicator | (0.16) |
Immix Biopharma November 22, 2024 Stock Price Analysis
Immix Stock Price History Data
The price series of Immix Biopharma for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 has a statistical range of 0.94 with a coefficient of variation of 13.36. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.73. The median price for the last 90 days is 1.68.Open | High | Low | Close | Volume | ||
11/22/2024 | 1.80 | 1.89 | 1.65 | 1.68 | ||
11/21/2024 | 1.80 | 1.89 | 1.65 | 1.68 | 372,923 | |
11/20/2024 | 1.70 | 1.93 | 1.65 | 1.82 | 439,940 | |
11/19/2024 | 1.67 | 1.78 | 1.65 | 1.70 | 91,698 | |
11/18/2024 | 1.58 | 1.80 | 1.58 | 1.69 | 113,368 | |
11/15/2024 | 1.61 | 1.64 | 1.54 | 1.59 | 57,115 | |
11/14/2024 | 1.59 | 1.66 | 1.57 | 1.62 | 36,372 | |
11/13/2024 | 1.69 | 1.74 | 1.55 | 1.57 | 57,786 | |
11/12/2024 | 1.76 | 1.78 | 1.69 | 1.72 | 39,264 | |
11/11/2024 | 1.91 | 1.91 | 1.75 | 1.77 | 70,365 | |
11/08/2024 | 1.75 | 1.95 | 1.70 | 1.86 | 167,627 | |
11/07/2024 | 1.56 | 1.78 | 1.53 | 1.75 | 90,916 | |
11/06/2024 | 1.64 | 1.65 | 1.57 | 1.60 | 91,587 | |
11/05/2024 | 1.58 | 1.60 | 1.48 | 1.60 | 65,563 | |
11/04/2024 | 1.57 | 1.62 | 1.54 | 1.58 | 28,393 | |
11/01/2024 | 1.66 | 1.66 | 1.55 | 1.59 | 29,518 | |
10/31/2024 | 1.66 | 1.66 | 1.57 | 1.60 | 49,001 | |
10/30/2024 | 1.66 | 1.71 | 1.62 | 1.65 | 51,696 | |
10/29/2024 | 1.66 | 1.76 | 1.63 | 1.71 | 78,316 | |
10/28/2024 | 1.69 | 1.77 | 1.62 | 1.68 | 52,726 | |
10/25/2024 | 1.60 | 1.67 | 1.56 | 1.66 | 128,218 | |
10/24/2024 | 1.64 | 1.65 | 1.58 | 1.59 | 40,575 | |
10/23/2024 | 1.66 | 1.66 | 1.57 | 1.63 | 54,336 | |
10/22/2024 | 1.58 | 1.67 | 1.53 | 1.65 | 67,305 | |
10/21/2024 | 1.72 | 1.75 | 1.58 | 1.60 | 83,418 | |
10/18/2024 | 1.75 | 1.79 | 1.70 | 1.72 | 111,030 | |
10/17/2024 | 1.46 | 1.99 | 1.46 | 1.69 | 383,505 | |
10/16/2024 | 1.46 | 1.51 | 1.39 | 1.44 | 99,575 | |
10/15/2024 | 1.37 | 1.54 | 1.36 | 1.46 | 245,870 | |
10/14/2024 | 1.46 | 1.51 | 1.38 | 1.38 | 79,448 | |
10/11/2024 | 1.36 | 1.50 | 1.36 | 1.45 | 70,373 | |
10/10/2024 | 1.53 | 1.55 | 1.36 | 1.38 | 95,859 | |
10/09/2024 | 1.53 | 1.59 | 1.44 | 1.54 | 77,729 | |
10/08/2024 | 1.51 | 1.67 | 1.49 | 1.53 | 209,832 | |
10/07/2024 | 1.67 | 1.80 | 1.41 | 1.45 | 364,163 | |
10/04/2024 | 1.34 | 1.66 | 1.26 | 1.63 | 471,898 | |
10/03/2024 | 1.48 | 1.49 | 1.32 | 1.34 | 179,873 | |
10/02/2024 | 1.50 | 1.51 | 1.44 | 1.46 | 329,418 | |
10/01/2024 | 1.47 | 1.54 | 1.45 | 1.48 | 64,229 | |
09/30/2024 | 1.54 | 1.56 | 1.43 | 1.49 | 161,648 | |
09/27/2024 | 1.59 | 1.59 | 1.54 | 1.56 | 50,524 | |
09/26/2024 | 1.62 | 1.65 | 1.52 | 1.59 | 149,402 | |
09/25/2024 | 1.62 | 1.69 | 1.60 | 1.65 | 57,196 | |
09/24/2024 | 1.68 | 1.72 | 1.60 | 1.64 | 136,393 | |
09/23/2024 | 1.79 | 1.82 | 1.64 | 1.68 | 171,739 | |
09/20/2024 | 1.78 | 1.84 | 1.74 | 1.80 | 96,643 | |
09/19/2024 | 1.83 | 1.87 | 1.76 | 1.77 | 75,120 | |
09/18/2024 | 1.82 | 1.88 | 1.78 | 1.78 | 80,063 | |
09/17/2024 | 1.81 | 1.95 | 1.81 | 1.81 | 87,459 | |
09/16/2024 | 1.90 | 1.95 | 1.81 | 1.85 | 31,500 | |
09/13/2024 | 1.87 | 1.88 | 1.84 | 1.86 | 41,397 | |
09/12/2024 | 1.86 | 1.93 | 1.81 | 1.81 | 39,572 | |
09/11/2024 | 1.91 | 1.91 | 1.80 | 1.86 | 65,667 | |
09/10/2024 | 2.02 | 2.02 | 1.84 | 1.90 | 163,975 | |
09/09/2024 | 2.00 | 2.04 | 1.94 | 1.97 | 45,128 | |
09/06/2024 | 2.11 | 2.14 | 1.95 | 1.97 | 147,521 | |
09/05/2024 | 2.03 | 2.14 | 2.01 | 2.10 | 50,729 | |
09/04/2024 | 2.06 | 2.11 | 2.01 | 2.01 | 50,821 | |
09/03/2024 | 2.11 | 2.19 | 2.04 | 2.04 | 49,072 | |
08/30/2024 | 2.11 | 2.20 | 2.09 | 2.14 | 71,541 | |
08/29/2024 | 2.21 | 2.26 | 2.10 | 2.12 | 39,458 |
About Immix Biopharma Stock history
Immix Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immix Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immix Biopharma stock prices may prove useful in developing a viable investing in Immix Biopharma
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 17.3 M | 13.1 M | |
Net Loss | -7.4 M | -7.8 M |
Immix Biopharma Stock Technical Analysis
Immix Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
All Next | Launch Module |
Immix Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immix Biopharma's price direction in advance. Along with the technical and fundamental analysis of Immix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.45) | |||
Total Risk Alpha | (1.04) | |||
Treynor Ratio | (0.26) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Immix Stock Analysis
When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.